C88.40 Código facturable y específico Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] not having achieved remission

ICD-10-CM C88.40 identifies “Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] not having achieved remission” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Capítulo 2: Neoplasms

Instrucciones del código

Inclusion terms8
  • Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] NOS
  • Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] with failed remission
  • Lymphoma of bronchial-associated lymphoid tissue [BALT-lymphoma] NOS
  • Lymphoma of bronchial-associated lymphoid tissue [BALT-lymphoma] not having achieved remission
  • Lymphoma of bronchial-associated lymphoid tissue [BALT-lymphoma] with failed remission
  • Lymphoma of skin-associated lymphoid tissue [SALT-lymphoma] NOS
  • Lymphoma of skin-associated lymphoid tissue [SALT-lymphoma] not having achieved remission
  • Lymphoma of skin-associated lymphoid tissue [SALT-lymphoma] with failed remission

Instrucciones de niveles superiores

Capítulos 2 · Neoplasms (C00-D49)

Note8
  • Functional activity
  • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
  • Morphology [Histology]
  • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
  • Primary malignant neoplasms overlapping site boundaries
  • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
  • Malignant neoplasm of ectopic tissue
  • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).

C81-C96 · Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)

Excludes 24
  • Kaposi's sarcoma of lymph nodes (C46.3)
  • secondary and unspecified neoplasm of lymph nodes (C77.-)
  • secondary neoplasm of bone marrow (C79.52)
  • secondary neoplasm of spleen (C78.89)

C88 · Malignant immunoproliferative diseases and certain other B-cell lymphomas

Excludes 12
  • B-cell lymphoma, unspecified (C85.1-)
  • personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues (Z85.79)

C88.4 · Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]

Inclusion terms2
  • Lymphoma of skin-associated lymphoid tissue [SALT-lymphoma]
  • Lymphoma of bronchial-associated lymphoid tissue [BALT-lymphoma]
Excludes 11

high malignant (diffuse large B-cell) lymphoma (C83.3-)

Referencias del índice oficial

Historial oficial de conversión

Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.

Fechas de vigencia 2024-10-01

Asignación anterior: C88.4

Historial

Historial del código

Último cambio registrado · FY2025

ModificadoSin cambios
FY2025

Vigente desde

  • Añadido

Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] not having achieved remission

Código de diagnóstico facturable

CDC/NCHS · FY2025

Todas las ediciones (5)

Todas las edicionesVigente desdeHistorial del código
FY20252024-10-01Añadido
FY2025 · 04-012025-04-01Sin cambios tabulares
FY20262025-10-01Sin cambios tabulares
FY2026 · April2026-04-01Sin cambios tabulares
FY20272026-10-01Sin cambios tabulares

Esta entrada es un código completo en la edición seleccionada. La comprobación del catálogo no establece la pertinencia clínica ni garantiza el reembolso.